[HTML][HTML] Dissecting the roles of prosaposin as an emerging therapeutic target for tumors and its underlying mechanisms

L Yan, Z Wen, Y Yang, A Liu, F Li, Y Zhang… - Biomedicine & …, 2024 - Elsevier
As a dual-function protein, prosaposin (PSAP) is a lysosome-associated protein that
participates in a variety of cellular processes. In the lysosome, PSAP is processed to activate …

Prosaposin promotes the proliferation and tumorigenesis of glioma through toll-like receptor 4 (TLR4)-mediated NF-κB signaling pathway

Y Jiang, J Zhou, P Luo, H Gao, Y Ma, YS Chen, L Li… - …, 2018 - thelancet.com
Background As a neurotrophic factor, prosaposin (PSAP) can exert neuroprotective and
neurotrophic effects. It is involved in the occurrence and development of prostate and breast …

[HTML][HTML] HtrA1: Its future potential as a novel biomarker for cancer

E Altobelli, D Marzioni, A Lattanzi… - Oncology …, 2015 - spandidos-publications.com
HtrA1 appears to be involved in several physiological processes as well as in the
pathogenesis of conditions such as Alzheimer's disease and osteoarthritis. It has also been …

Prosaposin is a biomarker of mesenchymal glioblastoma and regulates mesenchymal transition through the TGF‐β1/Smad signaling pathway

Y Jiang, J Zhou, D Hou, P Luo, H Gao… - The Journal of …, 2019 - Wiley Online Library
Mesenchymal glioblastoma (GBM) is the most aggressive subtype of GBM. Our previous
study found that neurotrophic factor prosaposin (PSAP) is highly expressed and secreted in …

Putative biomarkers for malignant pleural mesothelioma suggested by proteomic analysis of cell secretome

S Lacerenza, F Ciregia, L Giusti… - Cancer genomics & …, 2020 - cgp.iiarjournals.org
Background: Malignant pleural mesothelioma (MPM) a rare neoplasm linked to asbestos
exposure is characterized by a poor prognosis. Soluble mesothelin is currently considered …

Macrophage migration inhibitory factor-a therapeutic target in gallbladder cancer

T Subbannayya, P Leal-Rojas, MA Barbhuiya, R Raja… - BMC cancer, 2015 - Springer
Background Poor prognosis in gallbladder cancer is due to late presentation of the disease,
lack of reliable biomarkers for early diagnosis and limited targeted therapies. Early …

Global methylation profiling to identify epigenetic signature of gallbladder cancer and gallstone disease

P Sharma, S Bhunia, SS Poojary, DS Tekcham… - Tumor Biology, 2016 - Springer
Promoter methylation in various tumor suppressor genes is reported to influence gallbladder
carcinogenesis. Here, we aimed to identify methylation status in gallbladder cancer (GBC) …

Circular RNA circVAPA promotes cell proliferation in hepatocellular carcinoma

C Liu, X Zhong, J Li, F Xu - Human Gene Therapy Clinical …, 2019 - liebertpub.com
Hepatocellular carcinoma (HCC) is the most common malignancy in liver and is one of the
leading causes of cancer-induced deaths all over the world. Circular RNAs (circRNAs) have …

[HTML][HTML] Increased expression of tissue/salivary transgelin mrna predicts poor prognosis in patients with oral squamous cell carcinoma (OSCC) surgery

J Bu, X Bu, B Liu, F Chen, P Chen - Medical Science Monitor …, 2015 - ncbi.nlm.nih.gov
Background Transgelin is supposed to be a tumor suppression gene and it is down-
regulated in a variety of human cancers. However, the role of transgelin in different cancers …

Disease specific urinary biomarkers in the central nervous system

M Duggins-Warf, A Ghalali, J Sesen, T Martinez… - Scientific Reports, 2023 - nature.com
Urinary biomarkers can diagnose and monitor pathophysiologic conditions in the central
nervous system (CNS). However, focus is often on single diseases, with limited data on …